Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Finranks

Kompaniya

  • Biz haqimizda

Biz bilan bog'lanish

  • [email protected]

Bizni kuzating

  • Instagram
  • Telegram
  • LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari
  • Bosh sahifa
  • Bozorlar
  • Skriner
  • Yangiliklar
  • Biz haqimizda
  1. Home
  2. ACH

(ACH)

NYQ – Real vaqt narxi. Valyuta: USD

2.09

-0.01 (-0.48%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

2.09

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 7:56 PM EDT

  • Umumiy
  • Yangiliklar
  • Grafik
  • Hisobotlar
  • Dividendlar
  • Kutilma
  • Egalik
  • Profil
Is the Options Market Predicting a Spike in Accendra Health Stock?
13.03.2026

Is the Options Market Predicting a Spike in Accendra Health Stock?

Investors need to pay close attention to Accendra Health stock based on the movements in the options market lately.

Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade)
20.02.2026

Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade)

Accendra Health is upgraded to "Buy" after severe underperformance, trading at just 2x 2027 free cash flow. ACH faces significant margin pressure and a challenging balance sheet, with net leverage expected at 4.9-5x by end-2026. 2026 is likely a trough year due to a major contract loss; growth is expected to resume in 2027, aided by UnitedHealth volumes.

Accendra Health, Inc. (ACH) Q4 2025 Earnings Call Transcript
20.02.2026

Accendra Health, Inc. (ACH) Q4 2025 Earnings Call Transcript

Accendra Health, Inc. (ACH) Q4 2025 Earnings Call Transcript

Accendra Health Reports Fourth Quarter 2025 Financial Results
19.02.2026

Accendra Health Reports Fourth Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are.

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
05.02.2026

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 105.

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”
02.01.2026

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, “ACH”, effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This rele.

Videolar

No Data

There is no data to display

Press-relizlar

Accendra Health Reports Fourth Quarter 2025 Financial Results
19.02.2026

Accendra Health Reports Fourth Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are.

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”
02.01.2026

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, “ACH”, effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This rele.